Product Highlight - ACTRANEX

17 Aug 2022
Product Highlight - ACTRANEX
  • Pillar of the Patient Blood Management programs of transfusion medicine.1
  •  Reduces the risk of death in bleeding trauma patients.2
  •  Takes control of Post Partum Hemorrhage.3
  •  Effective and safest antifibrinolytic.4

 

Reference:
1 Franchini M, Muñoz M. Towards the implementation of patient blood manage-ment across Europe. Blood Transfus. 2017;15(4):292-293.
2 Lancet 2010; 376: 23–32. June 15, 2010.
3 www.thelancet.com vol 376 July 3, 2010.
4 Gayet­Ageron A, Prieto­Merino D, Ker K, Shakur H, Ageron F, Roberts I. Effect of treatment delay on the effectiveness and safety of antifibrinolytics in acute severe haemorrhage: a meta­analysis of individual patient­level data from 40 138 bleeding patients. Lancet 2018; 391: 125–32.


Related MIMS Drugs

Editor's Recommendations